Insulet
PODD
796 hedge funds and large institutions have $22B invested in Insulet in 2025 Q2 according to their latest regulatory filings, with 140 funds opening new positions, 299 increasing their positions, 269 reducing their positions, and 55 closing their positions.
155% more first-time investments, than exits
New positions opened: 140 | Existing positions closed: 55
18% more capital invested
Capital invested by funds: $18.6B → $22B (+$3.41B)
11% more repeat investments, than reductions
Existing positions increased: 299 | Existing positions reduced: 269
11% more funds holding
Funds holding: 719 → 796 (+77)
1.28% less ownership
Funds ownership: 100.9% → 99.62% (-1.3%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
56% less call options, than puts
Call options by funds: $92.1M | Put options by funds: $209M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$181M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$121M |
| 3 |
Goldman Sachs
New York
|
+$118M |
| 4 |
Two Sigma Investments
New York
|
+$100M |
| 5 |
WorldQuant Millennium Advisors
New York
|
+$73.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$387M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$156M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$118M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$93.9M |
| 5 |
Primecap Management
Pasadena,
California
|
-$68.2M |
PODD Hedge Fund Activity: Q2 2025 in Review
796 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q2 2025, worth a combined $22B — up 18% from $18.6B a quarter earlier.
Buyers outnumbered sellers: 140 funds opened new PODD positions and 55 closed out — a net gain of 85 holders — while 299 added to existing stakes and 269 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $181M. The largest seller was Capital Research Global Investors, cutting an estimated $387M.
- 796 institutional investors held Insulet (PODD) as of Q2 2025, up from 719 in Q1 2025.
- Funds reported $22B of Insulet stock for Q2 2025, up 18% quarter-over-quarter.
- 140 funds opened new Insulet positions in Q2 2025 and 55 closed out, a net change of +85 holders.
- The largest Insulet buyer in Q2 2025 was Citadel Advisors, an estimated $181M added.
- The largest Insulet seller in Q2 2025 was Capital Research Global Investors, an estimated $387M sold.
Based on aggregated 13F filings for Q2 2025.